Commonwealth Equity Services’s LianBio American Depositary Shares LIAN Stock Holding History

Commonwealth Equity Services’s Portfolio LIAN Stock Details LIAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,830	Closed	-$48K	–	4130
2023 Q4	$48K	Hold	10,830	–	–	﹤0.01%	3761
2023 Q3	$16K	Sell	10,830 -6,000	-36%	-$11.4K	﹤0.01%	3751
2023 Q2	$38K	Buy	16,830 +3,000	+22%	+$6.9K	﹤0.01%	3695
2023 Q1	$27	Buy	13,830 +3,000	+28%	+$6.21K	﹤0.01%	3648
2022 Q4	$17K	Hold	10,830	–	–	﹤0.01%	3614
2022 Q3	$21K	Hold	10,830	–	–	﹤0.01%	3578
2022 Q2	$23K	Buy	+10,830	New	+$36.8K	﹤0.01%	3562

Other funds holding LIAN

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Commonwealth Equity Services's LIAN Position: Q1 2024 in Review

Commonwealth Equity Services sold out of LianBio American Depositary Shares (LIAN) in Q1 2024, closing a stake of 10,830 shares — an estimated $48K sold.

Commonwealth Equity Services first reported a position in LIAN in Q2 2022 and held it in 7 quarters. The position peaked at $48K in Q4 2023. 3 funds tracked by Wall St. Rank hold LIAN as of Q1 2024.

Commonwealth Equity Services reported no remaining LianBio American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Commonwealth Equity Services sold 10,830 LianBio American Depositary Shares shares in Q1 2024, an estimated $48K.
Commonwealth Equity Services first reported a position in LianBio American Depositary Shares in Q2 2022 and held it in 7 quarters.
Commonwealth Equity Services's LianBio American Depositary Shares position peaked at $48K in Q4 2023.
3 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2024.

Based on Commonwealth Equity Services's 13F filing for Q1 2024, filed 29 Apr 2024.